A citation-based method for searching scientific literature

C Callens, I C Moura, Y Lepelletier, S Coulon, A Renand, M Dussiot, D Ghez, M Benhamou, R C Monteiro, A Bazarbachi, O Hermine. Leukemia 2008
Times Cited: 40







List of co-cited articles
464 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A neutralizing monoclonal antibody (mAb A24) directed against the transferrin receptor induces apoptosis of tumor T lymphocytes from ATL patients.
Ivan C Moura, Yves Lepelletier, Bertrand Arnulf, Patrick England, Cedric Baude, Carole Beaumont, Ali Bazarbachi, Marc Benhamou, Renato C Monteiro, Olivier Hermine. Blood 2004
84
37

The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer.
Tracy R Daniels, Tracie Delgado, Jose A Rodriguez, Gustavo Helguera, Manuel L Penichet. Clin Immunol 2006
412
37

The transferrin receptor and the targeted delivery of therapeutic agents against cancer.
Tracy R Daniels, Ezequiel Bernabeu, José A Rodríguez, Shabnum Patel, Maggie Kozman, Diego A Chiappetta, Eggehard Holler, Julia Y Ljubimova, Gustavo Helguera, Manuel L Penichet. Biochim Biophys Acta 2012
433
25

The transferrin receptor part II: targeted delivery of therapeutic agents into cancer cells.
Tracy R Daniels, Tracie Delgado, Gustavo Helguera, Manuel L Penichet. Clin Immunol 2006
347
22


Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting.
Kunihiro Tsukasaki, Olivier Hermine, Ali Bazarbachi, Lee Ratner, Juan Carlos Ramos, William Harrington, Deirdre O'Mahony, John E Janik, Achiléa L Bittencourt, Graham P Taylor,[...]. J Clin Oncol 2009
372
20

An anti-transferrin receptor-avidin fusion protein exhibits both strong proapoptotic activity and the ability to deliver various molecules into cancer cells.
Patrick P Ng, Jay S Dela Cruz, David N Sorour, James M Stinebaugh, Seung-Uon Shin, Daniel S Shin, Sherie L Morrison, Manuel L Penichet. Proc Natl Acad Sci U S A 2002
61
20



VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801.
Kunihiro Tsukasaki, Atae Utsunomiya, Haruhiko Fukuda, Taro Shibata, Takuya Fukushima, Yoshifusa Takatsuka, Shuichi Ikeda, Masato Masuda, Haruhisa Nagoshi, Ryuzo Ueda,[...]. J Clin Oncol 2007
329
17

Phase Ia trial of murine immunoglobulin A antitransferrin receptor antibody 42/6.
D Brooks, C Taylor, B Dos Santos, H Linden, A Houghton, T T Hecht, S Kornfeld, R Taetle. Clin Cancer Res 1995
46
17

The interleukin-2 receptor: a target for monoclonal antibody treatment of human T-cell lymphotrophic virus I-induced adult T-cell leukemia.
T A Waldmann, J D White, C K Goldman, L Top, A Grant, R Bamford, E Roessler, I D Horak, S Zaknoen, C Kasten-Sportes. Blood 1993
164
15

Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine.
P S Gill, W Harrington, M H Kaplan, R C Ribeiro, J M Bennett, H A Liebman, M Bernstein-Singer, B M Espina, L Cabral, S Allen. N Engl J Med 1995
285
15

Brief report: treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfa.
O Hermine, D Bouscary, A Gessain, P Turlure, V Leblond, N Franck, A Buzyn-Veil, B Rio, E Macintyre, F Dreyfus. N Engl J Med 1995
204
15


Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma.
Kazuhito Yamamoto, Atae Utsunomiya, Kensei Tobinai, Kunihiro Tsukasaki, Naokuni Uike, Kimiharu Uozumi, Kazunari Yamaguchi, Yasuaki Yamada, Shuichi Hanada, Kazuo Tamura,[...]. J Clin Oncol 2010
257
15

Molecular events contributing to cell death in malignant human hematopoietic cells elicited by an IgG3-avidin fusion protein targeting the transferrin receptor.
Patrick P Ng, Gustavo Helguera, Tracy R Daniels, Simon Z Lomas, Jose A Rodriguez, Gary Schiller, Benjamin Bonavida, Sherie L Morrison, Manuel L Penichet. Blood 2006
43
15




Development of human single-chain antibodies to the transferrin receptor that effectively antagonize the growth of leukemias and lymphomas.
Ronan Crépin, Anne-Laure Goenaga, Betsy Jullienne, Houcine Bougherara, Christine Legay, Karim Benihoud, James D Marks, Marie-Alix Poul. Cancer Res 2010
38
15

The in vitro antitumor effect and in vivo tumor-specificity distribution of human-mouse chimeric antibody against transferrin receptor.
Ye Qing, Wang Shuo, Wang Zhihua, Zhu Huifen, Lei Ping, Liu Lijiang, Zhao Xiaorong, Chao Liming, Xiao Daiwen, Huang Yu,[...]. Cancer Immunol Immunother 2006
31
19

Development of a complete human IgG monoclonal antibody to transferrin receptor 1 targeted for adult T-cell leukemia/lymphoma.
Shunsuke Shimosaki, Shingo Nakahata, Tomonaga Ichikawa, Akira Kitanaka, Takuro Kameda, Tomonori Hidaka, Yoko Kubuki, Gene Kurosawa, Lilin Zhang, Yukio Sudo,[...]. Biochem Biophys Res Commun 2017
22
27

Arsenic trioxide and interferon-alpha synergize to induce cell cycle arrest and apoptosis in human T-cell lymphotropic virus type I-transformed cells.
A Bazarbachi, M E El-Sabban, R Nasr, F Quignon, C Awaraji, J Kersual, L Dianoux, Y Zermati, J H Haidar, O Hermine,[...]. Blood 1999
141
12

Prevention of mantle lymphoma tumor establishment by routing transferrin receptor toward lysosomal compartments.
Yves Lepelletier, Valérie Camara-Clayette, Hulin Jin, Aurélie Hermant, Séverine Coulon, Michaël Dussiot, Michelle Arcos-Fajardo, Cédric Baude, Danielle Canionni, Richard Delarue,[...]. Cancer Res 2007
28
17


A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303.
Y Yamada, M Tomonaga, H Fukuda, S Hanada, A Utsunomiya, M Tara, M Sano, S Ikeda, K Takatsuki, M Kozuru,[...]. Br J Haematol 2001
274
12

Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL).
Ghada Kchour, Mahdi Tarhini, Mohamad-Mehdi Kooshyar, Hiba El Hajj, Eric Wattel, Mahmoud Mahmoudi, Hassan Hatoum, Hossein Rahimi, Masoud Maleki, Houshang Rafatpanah,[...]. Blood 2009
129
12


Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia/lymphoma showing improved survival in the leukemic subtypes.
Ali Bazarbachi, Yves Plumelle, Juan Carlos Ramos, Patricia Tortevoye, Zaher Otrock, Graham Taylor, Antoine Gessain, William Harrington, Gérard Panelatti, Olivier Hermine. J Clin Oncol 2010
234
12

Targeting hypoxia-inducible factor-1alpha with Tf-PEI-shRNA complex via transferrin receptor-mediated endocytosis inhibits melanoma growth.
Yeqiang Liu, Juan Tao, Yan Li, Jing Yang, Yan Yu, Min Wang, Xiaoyuan Xu, Changzheng Huang, Wei Huang, Jing Dong,[...]. Mol Ther 2009
41
12

Conjugation of an anti transferrin receptor IgG3-avidin fusion protein with biotinylated saporin results in significant enhancement of its cytotoxicity against malignant hematopoietic cells.
Tracy R Daniels, Patrick P Ng, Tracie Delgado, Maureen R Lynch, Gary Schiller, Gustavo Helguera, Manuel L Penichet. Mol Cancer Ther 2007
31
16

An antibody-based multifaceted approach targeting the human transferrin receptor for the treatment of B-cell malignancies.
Tracy R Daniels, Elizabeth Ortiz-Sánchez, Rosendo Luria-Pérez, Rafaela Quintero, Gustavo Helguera, Benjamin Bonavida, Otoniel Martínez-Maza, Manuel L Penichet. J Immunother 2011
20
25

Binding specificity and internalization properties of an antibody-avidin fusion protein targeting the human transferrin receptor.
José A Rodríguez, Gustavo Helguera, Tracy R Daniels, Isabel I Neacato, Héctor E López-Valdés, Andrew C Charles, Manuel L Penichet. J Control Release 2007
25
20

Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen.
Hany Onsy Habashy, Desmond G Powe, Cindy M Staka, Emad A Rakha, Graham Ball, Andrew R Green, Mohammed Aleskandarany, E Claire Paish, R Douglas Macmillan, Robert I Nicholson,[...]. Breast Cancer Res Treat 2010
143
12

Insights into the mechanism of cell death induced by saporin delivered into cancer cells by an antibody fusion protein targeting the transferrin receptor 1.
Tracy R Daniels-Wells, Gustavo Helguera, José A Rodríguez, Lai Sum Leoh, Michael A Erb, Graciel Diamante, David Casero, Matteo Pellegrini, Otoniel Martínez-Maza, Manuel L Penichet. Toxicol In Vitro 2013
23
21

Lethal iron deprivation induced by non-neutralizing antibodies targeting transferrin receptor 1 in malignant B cells.
José A Rodríguez, Rosendo Luria-Pérez, Héctor E López-Valdés, David Casero, Tracy R Daniels, Shabnum Patel, David Avila, Richard Leuchter, Sokuntheavy So, Elizabeth Ortiz-Sánchez,[...]. Leuk Lymphoma 2011
17
29

Efficacy of an Anti-transferrin Receptor 1 Antibody Against AIDS-related Non-Hodgkin Lymphoma: A Brief Communication.
Tracy R Daniels-Wells, Daniel P Widney, Lai Sum Leoh, Otoniel Martínez-Maza, Manuel L Penichet. J Immunother 2015
12
41


Radioimmunotherapy of interleukin-2R alpha-expressing adult T-cell leukemia with Yttrium-90-labeled anti-Tac.
T A Waldmann, J D White, J A Carrasquillo, J C Reynolds, C H Paik, O A Gansow, M W Brechbiel, E S Jaffe, T A Fleisher, C K Goldman,[...]. Blood 1995
196
10

Evidence against a direct cytotoxic effect of alpha interferon and zidovudine in HTLV-I associated adult T cell leukemia/lymphoma.
A Bazarbachi, R Nasr, M E El-Sabban, A Mahé, R Mahieux, A Gessain, N Darwiche, G Dbaibo, J Kersual, Y Zermati,[...]. Leukemia 2000
48
10

Arsenic/interferon specifically reverses 2 distinct gene networks critical for the survival of HTLV-1-infected leukemic cells.
Rihab Nasr, Andreas Rosenwald, Marwan E El-Sabban, Bertrand Arnulf, Pierre Zalloua, Yves Lepelletier, Françoise Bex, Olivier Hermine, Louis Staudt, Hugues de Thé,[...]. Blood 2003
77
10

Arsenic-interferon-alpha-triggered apoptosis in HTLV-I transformed cells is associated with tax down-regulation and reversal of NF-kappa B activation.
M E El-Sabban, R Nasr, G Dbaibo, O Hermine, N Abboushi, F Quignon, J C Ameisen, F Bex, H de Thé, A Bazarbachi. Blood 2000
121
10

Effective therapy for a murine model of adult T-cell leukemia with the humanized anti-CD52 monoclonal antibody, Campath-1H.
Zhuo Zhang, Meili Zhang, Carolyn K Goldman, Jeffrey V Ravetch, Thomas A Waldmann. Cancer Res 2003
82
10

Interferon alpha and zidovudine therapy in adult T-cell leukaemia lymphoma: response and outcome in 15 patients.
E Matutes, G P Taylor, J Cavenagh, A Pagliuca, D Bareford, A Domingo, M Hamblin, S Kelsey, N Mir, J T Reilly. Br J Haematol 2001
69
10

Clinical significance of CCR4 expression in adult T-cell leukemia/lymphoma: its close association with skin involvement and unfavorable outcome.
Takashi Ishida, Atae Utsunomiya, Shinsuke Iida, Hiroshi Inagaki, Yoshifusa Takatsuka, Shigeru Kusumoto, Genji Takeuchi, Shigeki Shimizu, Masato Ito, Hirokazu Komatsu,[...]. Clin Cancer Res 2003
257
10

Deoxycoformycin-containing combination chemotherapy for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study (JCOG9109).
Kunihiro Tsukasaki, Kensei Tobinai, Masanori Shimoyama, Mitsuo Kozuru, Naokuni Uike, Yasuaki Yamada, Masao Tomonaga, Koichi Araki, Masaharu Kasai, Kiyoshi Takatsuki,[...]. Int J Hematol 2003
61
10

A prospective phase II clinical trial with the use of zidovudine and interferon-alpha in the acute and lymphoma forms of adult T-cell leukemia/lymphoma.
Olivier Hermine, Isabelle Allard, Vincent Lévy, Bertrand Arnulf, Antoine Gessain, Ali Bazarbachi. Hematol J 2002
77
10

Effective therapy for a murine model of adult T-cell leukemia with the humanized anti-CD2 monoclonal antibody, MEDI-507.
Zhuo Zhang, Meili Zhang, Jeffrey V Ravetch, Carolyn Goldman, Thomas A Waldmann. Blood 2003
53
10

Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed/refractory adult T-cell leukemia/lymphoma.
Olivier Hermine, Hervé Dombret, Joel Poupon, Bertrand Arnulf, Francois Lefrère, Phillippe Rousselot, Gandhi Damaj, Richard Delarue, Jean Paul Fermand, Jean Claude Brouet,[...]. Hematol J 2004
98
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.